Zobrazeno 1 - 10
of 405
pro vyhledávání: '"Hongmei Zeng"'
Autor:
Zhenchao Fu, Huiqian Zhuang, Vincent Ninkuu, Jianpei Yan, Guangyue Li, Xiufen Yang, Hongmei Zeng
Publikováno v:
Journal of Integrative Agriculture, Vol 23, Iss 11, Pp 3774-3787 (2024)
Fusarium graminearum, the primary pathogenic fungus responsible for Fusarium head blight (FHB) in wheat, secretes abundant chemical compounds that interact with host plants. In this study, a secreted protein FgHrip1, isolated from the culture filtrat
Externí odkaz:
https://doaj.org/article/37b18a14b7824a86861086e992afd580
Autor:
Kexin Sun, Bailin Zhang, Shaoyuan Lei, Rongshou Zheng, Xin Liang, Li Li, Xiaolong Feng, Siwei Zhang, Hongmei Zeng, Yifei Yao, Peiqing Ma, Shaoming Wang, Ru Chen, Bingfeng Han, Wenqiang Wei, Jie He, Jing Ni
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 20, Pp 2429-2436 (2024)
Abstract. Background:. Breast cancer is ranked among the most prevalent malignancies in the Chinese female population. However, comprehensive reports detailing the latest epidemiological data and attributable disease burden have not been extensively
Externí odkaz:
https://doaj.org/article/664872f900d84d57aa08084c56c3b1e4
Autor:
Hongmei Zeng, Rongshou Zheng, Kexin Sun, Maigeng Zhou, Shaoming Wang, Li Li, Ru Chen, Bingfeng Han, Meicen Liu, Jinhui Zhou, Mengyuan Xu, Lijun Wang, Peng Yin, Baohua Wang, Jinling You, Jing Wu, Wenqiang Wei, Jie He
Publikováno v:
Journal of the National Cancer Center, Vol 4, Iss 3, Pp 203-213 (2024)
Background: A milestone goal of the Healthy China Program (2019–2030) is to achieve 5-year cancer survival at 43.3% for all cancers combined by 2022. To assess the progress towards this target, we analyzed the updated survival for all cancers combi
Externí odkaz:
https://doaj.org/article/47a4f7c996034e36a04a627f0dcdc9be
Autor:
Nana Guo, Qingxin Zhou, Meng Zhang, Xiaowei Chen, Baoqi Zeng, Shanshan Wu, Hongmei Zeng, Mopei Wang, Fei Ma, Feng Sun
Publikováno v:
Journal of the National Cancer Center, Vol 4, Iss 2, Pp 153-161 (2024)
Objective: Circulating tumor DNA (ctDNA) is increasingly being used as a potential prognostic biomarker in cancer patients. We aimed to assess the prognostic value of ctDNA in different subtypes of breast cancer patients throughout the whole treatmen
Externí odkaz:
https://doaj.org/article/689c57a237054c7c801fe76b03245eef
Autor:
Beatriz Rache, Rudi Rocha, Luciana Alves de Medeiros, Letícia Martins Okada, Gerson Ferrari, Hongmei Zeng, Alessandro Bigoni, Maria Paula Curado, Catarina M. Azeredo, Leandro F.M. Rezende
Publikováno v:
The Lancet Regional Health. Americas, Vol 39, Iss , Pp 100904- (2024)
Summary: Background: Cardiovascular disease (CVD) and cancer are the first and second leading causes of death in Brazil and worldwide. However, an ongoing epidemiological transition in which cancer surpasses CVD has been observed in many high and mid
Externí odkaz:
https://doaj.org/article/50256e76d3c1414b8caa5c2c5b8f929d
Autor:
Pei Li, Xueyang Zeng, Zuoxiang Liu, Jichun Yang, Yueying Li, Le Gao, Hongmei Zeng, Lin Zhang, Feng Sun, Yuanyuan Ji
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 12, Pp 1471-1473 (2024)
Externí odkaz:
https://doaj.org/article/536d4f79af0c4d4eb124384f5fad2dd5
Autor:
Bingfeng Han, Rongshou Zheng, Hongmei Zeng, Shaoming Wang, Kexin Sun, Ru Chen, Li Li, Wenqiang Wei, Jie He
Publikováno v:
Journal of the National Cancer Center, Vol 4, Iss 1, Pp 47-53 (2024)
Background: The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. The International Agency for Research on Cancer (IARC) calculates and publishes the cancer burden of countri
Externí odkaz:
https://doaj.org/article/a7ed423066aa492797247bad7d06cd4b
Publikováno v:
Journal of the National Cancer Center, Vol 4, Iss 1, Pp 63-73 (2024)
Objective: Circulating tumor DNA (ctDNA) is increasingly being used as a potential prognosis biomarker in patients of breast cancer. This review aims to assess the clinical value of ctDNA in outcome prediction in breast cancer patients throughout the
Externí odkaz:
https://doaj.org/article/5a3f626127bb40d6b7e7601a7b0df3ff
Autor:
Feifan He, Shaoming Wang, Rongshou Zheng, Jianhua Gu, Hongmei Zeng, Kexin Sun, Ru Chen, Li Li, Bingfeng Han, Xinqing Li, Wenqiang Wei, Jie He
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 44, Iss , Pp 101003- (2024)
Summary: Background: The incidence of gastric cancer (GC) decreased in past decades, which was thought largely attributable to risk factors control, yet China still accounts for 44% of global GC burdens. We aimed to estimate changing trajectories of
Externí odkaz:
https://doaj.org/article/b72e5da1e597481686b9d7f52e48bab1
Autor:
Xiaoying Guo, Yang Zhang, Zhiyi Zhang, Linzhi Lu, Yuqin Liu, Zhexuan Li, Tong Zhou, Jingying Zhang, Wenqing Li, Weicheng You, Guoquan Tao, Wanqing Chen, Hongmei Zeng, Kaifeng Pan
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12728-12738 (2023)
Abstract Background Effective noninvasive biomarkers of gastric cancer (GC) are critical for early detection and improvement of prognosis. We performed genome‐wide long non‐coding RNA (lncRNA) microarray analysis to identify and validate novel GC
Externí odkaz:
https://doaj.org/article/e09b8a768ee34d03a2dd3425fa2330d6